Omeros Stock Z Score

OMER Stock

USD 7.63 0.86 10.13%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Omeros Piotroski F Score and Omeros Valuation analysis.

To learn how to invest in Omeros Stock, please use our How to Invest in Omeros guide.

At this time, Omeros' Net Invested Capital is relatively stable compared to the past year. As of 12/15/2024, Net Working Capital is likely to grow to about 370.5 M, while Capital Lease Obligations is likely to drop slightly above 20.9 M. At this time, Omeros' Cost Of Revenue is relatively stable compared to the past year. As of 12/15/2024, Non Operating Income Net Other is likely to grow to about 3.8 M, while Interest Expense is likely to drop slightly above 9.7 M.

Omeros Company Z Score Analysis

Omeros' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Omeros Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Omeros is extremely important. It helps to project a fair market value of Omeros Stock properly, considering its historical fundamentals such as Z Score. Since Omeros' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Omeros' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Omeros' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Long Term Investments	Capital Stock
Total Assets		0.06	-0.4	0.9	-0.52	0.6	0.74	0.86	0.91	0.98	0.72	0.63	0.86	0.86	0.81	0.82	0.76	0.49	0.65	0.9	0.87	-0.46	0.86
Total Stockholder Equity	0.06		0.07	0.33	0.68	0.18	0.15	-0.08	-0.27	0.05	0.13	0.14	-0.17	-0.11	0.2	-0.14	-0.2	-0.03	-0.06	0.13	0.11	-0.07	-0.18
Current Deferred Revenue	-0.4	0.07		-0.38	0.27	-0.47	-0.24	-0.41	-0.39	-0.4	-0.15	-0.15	-0.39	-0.52	-0.16	-0.54	-0.67	-0.56	-0.59	-0.29	-0.27	0.17	-0.38
Net Debt	0.9	0.33	-0.38		-0.33	0.56	0.5	0.83	0.76	0.84	0.54	0.43	0.77	0.79	0.9	0.69	0.68	0.45	0.59	0.95	0.93	-0.69	0.81
Retained Earnings	-0.52	0.68	0.27	-0.33		-0.28	-0.21	-0.53	-0.7	-0.48	-0.23	-0.16	-0.6	-0.52	-0.44	-0.5	-0.55	-0.35	-0.39	-0.51	-0.5	0.32	-0.64
Accounts Payable	0.6	0.18	-0.47	0.56	-0.28		0.35	0.31	0.47	0.53	0.14	0.07	0.57	0.7	0.3	0.75	0.63	0.58	0.61	0.49	0.37	-0.1	0.52
Net Receivables	0.74	0.15	-0.24	0.5	-0.21	0.35		0.49	0.58	0.82	0.94	0.94	0.4	0.42	0.42	0.47	0.43	0.32	0.39	0.45	0.41	0.14	0.37
Short Term Investments	0.86	-0.08	-0.41	0.83	-0.53	0.31	0.49		0.82	0.86	0.59	0.51	0.81	0.79	0.79	0.69	0.78	0.53	0.69	0.82	0.86	-0.62	0.85
Total Liab	0.91	-0.27	-0.39	0.76	-0.7	0.47	0.58	0.82		0.87	0.6	0.5	0.87	0.81	0.74	0.78	0.75	0.38	0.55	0.85	0.83	-0.49	0.88
Total Current Assets	0.98	0.05	-0.4	0.84	-0.48	0.53	0.82	0.86	0.87		0.8	0.74	0.81	0.81	0.73	0.79	0.76	0.52	0.67	0.81	0.79	-0.33	0.79
Short Term Debt	0.72	0.13	-0.15	0.54	-0.23	0.14	0.94	0.59	0.6	0.8		0.98	0.4	0.34	0.56	0.36	0.37	0.16	0.25	0.53	0.54	-0.02	0.42
Common Stock	0.63	0.14	-0.15	0.43	-0.16	0.07	0.94	0.51	0.5	0.74	0.98		0.29	0.24	0.45	0.28	0.3	0.18	0.23	0.4	0.42	0.1	0.29
Property Plant Equipment	0.86	-0.17	-0.39	0.77	-0.6	0.57	0.4	0.81	0.87	0.81	0.4	0.29		0.93	0.66	0.89	0.8	0.44	0.62	0.84	0.81	-0.53	0.94
Long Term Debt	0.86	-0.11	-0.52	0.79	-0.52	0.7	0.42	0.79	0.81	0.81	0.34	0.24	0.93		0.56	0.96	0.9	0.65	0.82	0.76	0.71	-0.48	0.88
Net Tangible Assets	0.81	0.2	-0.16	0.9	-0.44	0.3	0.42	0.79	0.74	0.73	0.56	0.45	0.66	0.56		0.44	0.45	0.19	0.31	0.95	0.97	-0.75	0.76
Long Term Debt Total	0.82	-0.14	-0.54	0.69	-0.5	0.75	0.47	0.69	0.78	0.79	0.36	0.28	0.89	0.96	0.44		0.93	0.65	0.82	0.67	0.6	-0.26	0.85
Capital Surpluse	0.76	-0.2	-0.67	0.68	-0.55	0.63	0.43	0.78	0.75	0.76	0.37	0.3	0.8	0.9	0.45	0.93		0.73	0.87	0.62	0.6	-0.32	0.82
Deferred Long Term Liab	0.49	-0.03	-0.56	0.45	-0.35	0.58	0.32	0.53	0.38	0.52	0.16	0.18	0.44	0.65	0.19	0.65	0.73		0.93	0.29	0.27	-0.08	0.45
Short Long Term Debt	0.65	-0.06	-0.59	0.59	-0.39	0.61	0.39	0.69	0.55	0.67	0.25	0.23	0.62	0.82	0.31	0.82	0.87	0.93		0.45	0.42	-0.21	0.63
Net Invested Capital	0.9	0.13	-0.29	0.95	-0.51	0.49	0.45	0.82	0.85	0.81	0.53	0.4	0.84	0.76	0.95	0.67	0.62	0.29	0.45		0.99	-0.73	0.89
Net Working Capital	0.87	0.11	-0.27	0.93	-0.5	0.37	0.41	0.86	0.83	0.79	0.54	0.42	0.81	0.71	0.97	0.6	0.6	0.27	0.42	0.99		-0.77	0.87
Long Term Investments	-0.46	-0.07	0.17	-0.69	0.32	-0.1	0.14	-0.62	-0.49	-0.33	-0.02	0.1	-0.53	-0.48	-0.75	-0.26	-0.32	-0.08	-0.21	-0.73	-0.77		-0.59
Capital Stock	0.86	-0.18	-0.38	0.81	-0.64	0.52	0.37	0.85	0.88	0.79	0.42	0.29	0.94	0.88	0.76	0.85	0.82	0.45	0.63	0.89	0.87	-0.59

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict Omeros

Based on the company's disclosures, Omeros has a Z Score of 0.0. This is 100.0% lower than that of the Pharmaceuticals sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Omeros Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Omeros' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Omeros could also be used in its relative valuation, which is a method of valuing Omeros by comparing valuation metrics of similar companies.

Omeros is currently under evaluation in z score category among its peers.

Omeros Current Valuation Drivers

We derive many important indicators used in calculating different scores of Omeros from analyzing Omeros' financial statements. These drivers represent accounts that assess Omeros' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Omeros' important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	541.2M	697.8M	817.1M	141.8M	205.2M	289.0M
Enterprise Value	686.8M	730.5M	839.1M	472.8M	559.6M	360.6M

Omeros ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Omeros' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Omeros' managers, analysts, and investors.

Environmental

Governance

Social

Omeros Institutional Holders

Institutional Holdings refers to the ownership stake in Omeros that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Omeros' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Omeros' value.

		Shares
Royal Bank Of Canada	2024-09-30	497 K
Charles Schwab Investment Management Inc	2024-09-30	485 K
Ubs Group Ag	2024-09-30	450.1 K
Nomura Holdings Inc	2024-09-30	316.3 K
Morgan Stanley - Brokerage Accounts	2024-09-30	297.9 K
Goldman Sachs Group Inc	2024-09-30	178.2 K
Bank Of America Corp	2024-09-30	176.3 K
Bridgeway Capital Management, Llc	2024-09-30	161.3 K
Susquehanna Fundamental Investments, Llc	2024-06-30	156 K
Ingalls & Snyder Llc	2024-09-30	4.5 M
Blackrock Inc	2024-06-30	4.1 M

Omeros Fundamentals

	Return On Equity	-5.76
	Return On Asset	-0.27
	Current Valuation	528.47 M
	Shares Outstanding	57.95 M
	Shares Owned By Insiders	4.44 %
	Shares Owned By Institutions	43.67 %
	Number Of Shares Shorted	8.92 M
	Price To Earning	0.73 X
	Price To Book	8.44 X
	Price To Sales	4.93 X
	Gross Profit	(71.4 M)
	EBITDA	(163.61 M)
	Net Income	(117.81 M)
	Cash And Equivalents	122.56 M
	Cash Per Share	1.95 X
	Total Debt	361.58 M
	Current Ratio	5.01 X
	Book Value Per Share	(2.66) X
	Cash Flow From Operations	74.73 M
	Short Ratio	6.15 X
	Earnings Per Share	(3.14) X
	Price To Earnings To Growth	(0.17) X
	Target Price	43.0
	Number Of Employees	198
	Beta	1.48
	Market Capitalization	442.16 M
	Total Asset	378.27 M
	Retained Earnings	(753.53 M)
	Working Capital	306.85 M
	Current Asset	37.15 M
	Current Liabilities	16.25 M
	Net Asset	378.27 M

About Omeros Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Omeros's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Omeros using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Omeros based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Omeros

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Omeros position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omeros will appreciate offsetting losses from the drop in the long position's value.

Moving together with Omeros Stock

0.85	ESPR	Esperion Therapeutics	Pair Corr
0.74	BMY	Bristol Myers Squibb	Pair Corr

Moving against Omeros Stock

0.84	AMGN	Amgen Inc	Pair Corr
0.75	PFE	Pfizer Inc Fiscal Year End 4th of February 2025	Pair Corr
0.74	AVDL	Avadel Pharmaceuticals	Pair Corr
0.68	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.66	TTOO	T2 Biosystms	Pair Corr

The ability to find closely correlated positions to Omeros could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Omeros when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Omeros - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Omeros to buy it.

The correlation of Omeros is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Omeros moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Omeros moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Omeros can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Omeros Stock Analysis

When running Omeros' price analysis, check to measure Omeros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omeros is operating at the current time. Most of Omeros' value examination focuses on studying past and present price action to predict the probability of Omeros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omeros' price. Additionally, you may evaluate how the addition of Omeros to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Omeros Stock Z Score

Omeros Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Omeros Z Score Driver Correlations

Omeros Z Score Peer Comparison

Omeros Current Valuation Drivers

Omeros ESG Sustainability

Omeros Institutional Holders

Omeros Fundamentals

About Omeros Fundamental Analysis

Pair Trading with Omeros

Moving together with Omeros Stock

Moving against Omeros Stock

Additional Tools for Omeros Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY